Similar articles

• Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

  When To Start Consortium; Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, Dabis F, Miró JM, Justice AC, Ledergerber B, Fätkenheuer G, Hogg RS, Monforte AD, Saag M, Smith C, Staszewski S, Egger M, Cole SR. When To Start Consortium, et al. Lancet. 2009 Apr 18;373(9672):1352-63. doi: 10.1016/S0140-6736(09)60612-7. Epub 2009 Apr 8. Lancet. 2009. PMID: 19361855 Free PMC article. Review.
• Should the CD4 threshold for starting ART be raised?

  Wood R, Lawn SD. Wood R, et al. Lancet. 2009 Apr 18;373(9672):1314-6. doi: 10.1016/S0140-6736(09)60654-1. Epub 2009 Apr 8. Lancet. 2009. PMID: 19361856 No abstract available.
• HIV news from Buenos Aires: Part 1--the Zahir and the band-aid. 1st IAS conference on HIV pathogenesis and treatment. July 8-11, 2001, Buenos Aires.

  Mascolini M. Mascolini M. IAPAC Mon. 2001 Sep;7(9):274-89. IAPAC Mon. 2001. PMID: 11708272 No abstract available.
• Antiretroviral therapy for HIV: drug resistance and sequencing.

  Burkle WS. Burkle WS. J Assoc Nurses AIDS Care. 2002 Jan-Feb;13(1):76-80. doi: 10.1016/S1055-3290(06)60243-4. J Assoc Nurses AIDS Care. 2002. PMID: 11828862 Review. No abstract available.
• Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians.

  Mekonnen Y, Dukers NH, Sanders E, Dorigo W, Wolday D, Schaap A, Geskus RB, Coutinho RA, Fontanet A. Mekonnen Y, et al. Ethiop Med J. 2003 Jun;41 Suppl 1:61-5. Ethiop Med J. 2003. PMID: 15227882